QuickView for BRCA1;jsessionid=69052E120845B0F75D3DDDC3AD8FCC73;jsessionid=42BC63E25A85528EB899E0529D01FE99;jsessionid=80A36E72ECBDACA7098FC3AB3FCD56A3;jsessionid=332AEF2425A1D1AD0664871A4E13260E;jsessionid=C3158F8BA43228390AD051C945B9AC90;jsessionid=3A7988FFE0DD3BF944286A5F705CB8E7 (gene)

1. BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy.
2. Association of common BRCA1 variants with predisposition to breast tumors in Pakistan.
3. BRCA1 protects against its own fragility.
4. BRCA1: An Endocrine and Metabolic Regulator.
5. Bractoppin, a BRCA1 carboxy-terminal domain (BRCT) inhibitor, suppresses tumor progression in ovaria…

There were no clinical trials for BRCA1;jsessionid=69052E120845B0F75D3DDDC3AD8FCC73;jsessionid=42BC63E25A85528EB899E0529D01FE99;jsessionid=80A36E72ECBDACA7098FC3AB3FCD56A3;jsessionid=332AEF2425A1D1AD0664871A4E13260E;jsessionid=C3158F8BA43228390AD051C945B9AC90;jsessionid=3A7988FFE0DD3BF944286A5F705CB8E7